The financing round was led by Lytical Ventures with participation from Flashpoint and Sony Innovation Fund.
"We got pulled to the US market and saw a significant demand for our solution in the financial services sector. With this funding round we are increasing our sales and marketing efforts on the US and European markets. And we are also continuing to invest in our technical and product capabilities to automate compliance workflows and apply our data science models to the compliance content as one of the biggest challenges that heavily regulated firms are facing is keeping up with the volume of regulatory change."
The funding round was backed by Jefferies, Antara Capital, Sony Innovation Fund, and FM Capital.
"Over the past 9 years, we have developed a unique software platform that addresses the core challenges of electric vehicle fleets. From predictive maintenance and repair automation to fine-grain location and curb management, our platform is rich with advanced capabilities that enable safer and more reliable transportation solutions,"
Morningside led the Series B financing to support regulatory approvals and market entry for clinical software treatments.
"At ieso, we’re looking to transform global mental health by unlocking the power of clinical data to develop AI-enabled digital therapeutics. Our experience delivering outstanding mental health care within the NHS ideally places us for starting to tackle this challenge. A new generation of clinically-validated digital mental health care products could ultimately improve millions of lives. But we cannot do this alone, and look forward to working with our patients, clinicians, investors, as well as existing and future partners, to better serve those who require mental health support."
